NAT CANCER 润色咨询

Nature Cancer

出版年份:暂无数据 年文章数:187 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=51d016618, cover=https://img.medsci.cn/2020622/1592797322638_4754896.png, fullname=Nature Cancer, abbr=NAT CANCER, pyear=暂无数据, frequence=null, articleNumbers=187, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.25月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2662-1347, greenSci=https://www.greensci.net/search?kw=2662-1347, scijournal=https://www.scijournal.org/impact-factor-of-NAT-CANCER.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.083, medsciHotlight=10.62, medsciHotlight5year=3.25133, citescore=31.1, hIndex=0, impactFactor=22.7, orgnization=Springer Nature, orgnizationUrl=https://www.nature.com, country=null, countryCn=, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=, website=https://www.nature.com/natcancer, websiteHits=4217, guideForAuthor=https://www.nature.com/natcancer/for-authors, guideForAuthorHits=1777, submitWebsite=https://mts-natcancer.nature.com/, submitWebsiteHits=2526, content=<p style="color: #222222;">Cancer is a devastating disease that causes one in six deaths globally. A large proportion of these deaths could be prevented, but improving prevention and treatment outcomes requires accurate diagnosis, the development of effective and precise treatment modalities and a better understanding of the socioeconomic factors that affect cancer incidence, prevalence and mortality. </p> <p style="color: #222222;"><strong><em>Nature Cancer</em> </strong>aims to provide a unique forum through which the cancer community will learn about the latest, most significant cancer-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying tumour initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing cancer diagnosis, treatment and prevention; and new ways of understanding the global societal impact of cancer.</p> <p style="color: #222222;">In addition to publishing original research, <strong><em>Nature Cancer</em></strong> will publish Comments, Reviews, News & Views, Features and Correspondence of high significance across the range of disciplines relating to cancer research.</p> <p style="color: #222222;"> </p> <h2 style="color: #222222;">Topics covered in the journal include:</h2> <p style="color: #222222;"> </p> <p style="color: #222222;">• <strong>Cancer biology</strong>, encompassing oncogenic and tumour-suppressive mechanisms that deregulate molecular pathways and cellular processes, including tumour-initiating cells/cancer stem cells</p> <p style="color: #222222;">• <strong>Cancer genetics and genomics</strong>, including functional genomics and the mechanisms underlying genome integrity, genomic instability and mutation</p> <p style="color: #222222;">• <strong>Tumour evolution and heterogeneity</strong></p> <p style="color: #222222;">• <strong>Tumour–host interactions</strong>, including the tumour microenvironment (molecular, cellular, physical) and systemic effects</p> <p style="color: #222222;">• <strong>Tumour immunology and immunotherapy</strong></p> <p style="color: #222222;">• <strong>Metastasis</strong>, including mechanisms of cancer cell dissemination, seeding, dormancy and growth in secondary sites</p> <p style="color: #222222;">• <strong>Therapy</strong>, including design and delivery, targeted, combination and precision therapy and the study of therapy resistance</p> <p style="color: #222222;">• <strong>Clinical work</strong> that informs cancer diagnosis, treatment and prevention </p> <p style="color: #222222;">• <strong>Cancer models and methodology</strong> to investigate, diagnose and treat cancer</p> <p style="color: #222222;">• <strong>Systems biology</strong>, including large-scale and single-cell omics and multi-omics approaches to characterise and study cancer</p> <p style="color: #222222;">• <strong>Social, ethical and policy issues</strong> relating to cancer research, prevention, diagnosis and treatment</p>, totalCites=4262, brief=NAT CANCER杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=51d016618'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=4), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=3), ImpactFactorTagDto(id=65, tagName=治疗, createdHits=2), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=2), ImpactFactorTagDto(id=1047, tagName=转移, createdHits=2), ImpactFactorTagDto(id=16012, tagName=癌症免疫治疗, createdHits=2), ImpactFactorTagDto(id=125072, tagName=癌症基础研究, createdHits=2), ImpactFactorTagDto(id=104390, tagName=自然旗下, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=109, tagName=临床试验, createdHits=1), ImpactFactorTagDto(id=804, tagName=放疗, createdHits=1), ImpactFactorTagDto(id=1517, tagName=临床研究, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2023, citescore=31.1)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=9.754), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=11.244), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=9.736), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.083)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2662-1347[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Nature Cancer[ta], article_number=170, article_number_cn=16, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
NAT CANCER/Nature Cancer
ISSN
2662-1347
影响指数话题
预警等级
MedSci期刊指数
6.083 (MedSci实时期刊指数) | 3.25133 (5年期刊指数)
CiteScore值
31.1
h-index
0
h5-median
暂无数据
出版社/管理机构
杂志由 Springer Nature 出版或管理
出版国家/地区
出版周期
暂无数据
出版年份
暂无数据
是否OA
被收录情况
暂无数据
JCR分区
暂无数据
中科院分区
大类:
小类: